NovaBay Pharmaceuticals Inc at Ladenburg Thalmann Virtual Healthcare Conference Transcript
Good afternoon. This is Jeff Cohen Destiny Hance of Ladenburg Thalmann. Thanks for joining us. Next up we have NovaBay Pharmaceuticals. With us today from NovaBay is Justin Hall, President and CEO, General Counsel, Chief Compliance Officer, Corporate Secretary and Director; and with him is Andrew Jones, who is CFO and Treasurer of the Company. Thank you both for joining us. And Justin, I will give you the floor.
All right. Thanks, Jeff. So I am here with Andrew Jones, our CFO. Yes, happy to introduce NovaBay to everybody who is listening. So the NovaBay story really starts with Avenova. And Avenova is the number one antimicrobial lid and lash spray in the US dry-eye market. So we launched this commercially in 2016 to ophthalmologists and optometrists for the dry-eye and blepharitis space.
And so over the past five years during our commercialization strategy, we have developed several sales channels. The first being that prescription-only version of Avenova being
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
